Found: 36
Select item for more details and to access through your institution.
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2¯ Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group.
- Published in:
- Clinical Breast Cancer, 2011, v. 11, n. 4, p. 228, doi. 10.1016/j.clbc.2011.04.001
- By:
- Publication type:
- Article
A Phase II Neoadjuvant Trial of Sequential Nanoparticle Albumin-Bound Paclitaxel Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide in Locally Advanced Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 1, p. 81, doi. 10.3816/CBC.2010.n.011
- By:
- Publication type:
- Article
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 2, p. 243, doi. 10.1007/s10549-023-06881-8
- By:
- Publication type:
- Article
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 3, p. 555, doi. 10.1007/s10549-021-06417-y
- By:
- Publication type:
- Article
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 1, p. 161, doi. 10.1007/s10549-019-05453-z
- By:
- Publication type:
- Article
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 389, doi. 10.1007/s10549-019-05398-3
- By:
- Publication type:
- Article
Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1139347
- By:
- Publication type:
- Article
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 7, p. 1853, doi. 10.1245/s10434-016-5662-9
- By:
- Publication type:
- Article
Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 2, p. 398, doi. 10.1245/s10434-016-5571-y
- By:
- Publication type:
- Article
Metastatic HER2-Positive Breast Cancer: Tailoring Treatment Un-'TIL' We Get It Right...
- Published in:
- Oncology (08909091), 2016, v. 30, n. 2, p. 156
- By:
- Publication type:
- Article
HER2 Targeting in Early Breast Cancer: More Options and More Questions.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 4, p. 293
- By:
- Publication type:
- Article
Targeting Alternative Pathways in HER2-Positive Breast Cancer.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 5, p. 415
- By:
- Publication type:
- Article
Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 5, p. 1, doi. 10.1093/jncics/pkab066
- By:
- Publication type:
- Article
Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 5, p. 1, doi. 10.1093/jncics/pkaa058
- By:
- Publication type:
- Article
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00349-y
- By:
- Publication type:
- Article
Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00275-z
- By:
- Publication type:
- Article
NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00264-2
- By:
- Publication type:
- Article
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0090-6
- By:
- Publication type:
- Article
Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 164, n. 2, p. 371, doi. 10.1007/s10549-017-4265-x
- By:
- Publication type:
- Article
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
- Published in:
- 2011
- By:
- Publication type:
- Report
Correction to: Pterocarpus marsupium extract extends replicative lifespan in budding yeast.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.
- Published in:
- Breast Cancer: Targets & Therapy, 2017, v. 9, p. 95, doi. 10.2147/BCTT.S123785
- By:
- Publication type:
- Article
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 327, n. 20, p. 1963, doi. 10.1001/jama.2022.6147
- By:
- Publication type:
- Article
The Attitudes, Communication, Treatment, and Support Intervention to Reduce Breast Cancer Treatment Disparity.
- Published in:
- Oncology Nursing Forum, 2011, v. 38, n. 1, p. 85, doi. 10.1188/11.ONF.85-89
- By:
- Publication type:
- Article
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00639-1
- By:
- Publication type:
- Article
Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010–2014.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 481, doi. 10.1634/theoncologist.2017-0398
- By:
- Publication type:
- Article
Assessment of effect size and power for survival analysis through a binary surrogate endpoint in clinical trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Patient‐reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2–positive breast cancer
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1302, doi. 10.1093/jnci/djad078
- By:
- Publication type:
- Article
The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Metformin vs Placebo on Weight and Metabolic Factors in NCIC CTG MA.32.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 3, p. 1, doi. 10.1093/jnci/djv006
- By:
- Publication type:
- Article
Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 23, p. 1782, doi. 10.1093/jnci/djt321
- By:
- Publication type:
- Article